First identification of Ewing's sarcoma‐derived extracellular vesicles and exploration of their biological and potential diagnostic implications
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background Information: Exosomes are small RNA‐ and protein‐containing extracellular vesicles (EVs) that are thought to mediate hetero‐ and homotypic intercellular communication between normal and malignant cells. Tumour‐derived exosomes are believed to promote re‐programming of the tumour‐associated stroma to favour tumour growth and metastasis. Currently, exosomes have been intensively studied in carcinomas. However, little is known about their existence and possible role in sarcomas. Results: Here, we report on the identification of vesicles with exosomal features derived from Ewing's sarcoma (ES), the second most common soft‐tissue or bone cancer in children and adolescents. ES cell line‐derived EVs have been isolated by ultracentrifugation and analysed by flow‐cytometric assessment of the exosome‐associated proteins CD63 and CD81 as well as by electron microscopy. They proved to contain ES‐specific transcripts including EWS‐FLI1, which were suitable for the sensitive detection of ES cell line‐derived exosomes by qRT‐PCR in a pre‐clinical model for patient plasma. Microarray analysis of ES cell line‐derived exosomes revealed that they share a common transcriptional signature potentially involved in G‐protein‐coupled signalling, neurotransmitter signalling and stemness. Conclusions: In summary, our results imply that ES‐derived exosomes could eventually serve as biomarkers for minimal residual disease diagnostics in peripheral blood and prompt further investigation of their potential biological role in modification of the ES‐associated microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Syndecan–syntenin–ALIX regulates the biogenesis of exosomes
Baietti, M. F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2502 · Cited by 1,899
Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration
Luga, V., Zhang, L., Viloria-Petit, A. M., Ogunjimi, A. A., Inanlou, M. R., Chiu, E., Buchanan, M., Hosein, A. N., Basik, M., & Wrana, J. L. (2012) · Cell · doi:10.1016/j.cell.2012.11.024 · Cited by 1,311 · cited 2×
“In other cancers such as gastric and mammary carcinoma, recent evidence has shown that tumour-derived exosomes mobilise stromal cells and induce the differentiation of normal mesenchymal stem cells into cancerassociated fibroblasts by specifically delivering signalling molecules packed in exosomes into recipient cells…”
Svensson, K. J., Kucharzewska, P., Christianson, H. C., Sköld, S., Löfstedt, T., Johansson, M. C., Mörgelin, M., Bengzon, J., Ruf, W., & Belting, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104261108 · Cited by 288
Noerholm, M., Balaj, L., Limperg, T., Salehi, A., Zhu, L. D., Hochberg, F. H., Breakefield, X. O., Carter, B. S., & Skog, J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-22 · Cited by 190 · cited 2×
“…cargo of EVs offers the possibility to use them as specific tumour biomarkers, which was already shown in glioblastoma (Skog et al., 2008; Noerholm et al., 2012), melanoma (Logozzi et al., 2009; Peinado et al., 2012), prostate (Duijvesz et al., 2011; Bryant et al., 2012), ovarian (Keller…”
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Self-citationCancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development
Kok, V. C., & Yu, C.-C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272378 · Cited by 398
Sarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Self-citationEwing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Zöllner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Álava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081685 · Cited by 271
Aran, V., Devalle, S., Meohas, W., Heringer, M., Cunha Caruso, A., Pinheiro Aguiar, D., Leite Duarte, M. E., & Moura Neto, V. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103340 · Cited by 87
Metadata
- Authors
- Miller, I. V., Raposo, G., Welsch, U., Prazeres da Costa, O., Thiel, U., Lebar, M., Maurer, M., Bender, H., von Luettichau, I., Richter, G. H. S., Burdach, S., & Grunewald, T. G. P.
- Venue
- Biology of the Cell
- Publisher
- Wiley
- Published
- 2013-05-04
- Volume
- 105
- Issue
- 7
- Pages
- 289-303
- ISSN
- 0248-4900 (ISSN-L)
- 1768-322X
- OpenAlex
- W1666847802
- Cited by
- 70
- References
- 4
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.